| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Atara Biotherapeutics, Inc. (ATRA) has 10 insiders with recent SEC Form 4 filings, including 1 buy and 21 sells. ATRA is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| 10% | 1.32M | $11.05M | - | |
| 10% | 377.2K | $3.15M | - | |
| CEO | 143.1K | $1.19M | - | |
| ? | 78.0K | $650.1K | - | |
| Other | 52.0K | $434.1K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Feb 6, 2020 | Koppikar Utpal76 | Chief Financial Officer | Sell | 1,781 | $14.21 | $25,308.01 | -2.4% | |
| Sep 27, 2019 | Newell Joe85 | Chief Tech. Operations Officer | Sell | 3,500 | $13.51 | $47,285.00 | -5.7% | |
| Jun 27, 2019 | Dobmeier Eric | Director | Buy | 2,000 | $19.50 | $39,000.00 | +14.3% | |
| May 30, 2019 | Ciechanover Isaac E. | Chief Executive Officer | Sell | 5,850 | $23.09 | $135,088.50 | -0.5% | |
| May 14, 2019 | Ciechanover Isaac E. | Chief Executive Officer | Sell | 7,800 | $24.61 | $191,973.00 | -0.9% | |
| May 6, 2019 | Newell Joe85 | Chief Tech. Operations Officer | Sale+OE | 1,500 | $35.00 | $52,500.00 | -2.4% | |
| Apr 26, 2019 | Ciechanover Isaac E. | Chief Executive Officer | Sell | 7,800 | $33.54 | $261,582.00 | -0.8% | |
| Apr 11, 2019 | Ciechanover Isaac E. | Chief Executive Officer | Sell | 7,800 | $36.66 | $285,909.00 | -1.2% | |
| Apr 1, 2019 | Newell Joe85 | Chief Tech. Operations Officer | Sale+OE | 1,500 | $39.96 | $59,940.00 | -2.4% | |
| Mar 29, 2019 | Ciechanover Isaac E. | Chief Executive Officer | Sell | 7,800 | $38.66 | $301,546.00 | -0.5% |